Results 91 to 100 of about 267,377 (295)

Emerging Strategies for Platelet‐Modified Nanoparticles in Targeted Tumor Therapy

open access: yesAdvanced NanoBiomed Research, EarlyView.
This review highlights innovative strategies using platelet‐modified nanoparticles to target tumors more precisely. By mimicking platelet functions, these biomimetic carriers improve tumor homing, enhance drug delivery, and reduce immune clearance.
Chunyu Bai   +5 more
wiley   +1 more source

Hereditary Elliptocytosis Resulting From Heterozygosity for β Spectrin Tandil

open access: yes
American Journal of Hematology, EarlyView.
María‐Angustias Molina‐Arrebola   +1 more
wiley   +1 more source

Promoter polymorphisms in the JK*01 W.06 allele associated with the Jk(a + w) weak antigen phenotype

open access: yesBMC Immunology
Background The Kidd blood group system is critical in transfusion medicine, especially for delayed hemolytic reactions. However, the genetic background and molecular mechanisms underlying the weak antigen phenotype remain unclear.
Shuang Liang   +7 more
doaj   +1 more source

Optimizing jojoba oil methanolysis of cis‐13‐docosenol fatty alcohol to unveil its immunomodulatory potential: a circular biorefinery perspective

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract The sustainable production of jojoba oil derivatives depends on research and development focused on eco‐friendly valorization processes. This study establishes optimal conditions for converting jojoba oil into jojobyl alcohols, which is a key step in realizing its economic potential.
Laura Mendoza‐García   +3 more
wiley   +1 more source

BLOOD TRANSFUSION APPARATUS [PDF]

open access: yesJournal of the American Medical Association, 1920
This blood transfusion apparatus was devised and has been successfully used at the California State Prison, at San Quentin, Calif. It is of the ball valve plan, and may be used with any capacity Luer syringe. When the plunger of the syringe is drawn out, the ball A (Fig.
openaire   +3 more sources

The feasibility of pharmacokinetic‐based dosing of hydroxyurea for children with sickle cell anaemia in Uganda: Baseline results of the alternative dosing and prevention of transfusions trial

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Pharmacokinetic (PK)‐guided dosing of hydroxyurea for children with sickle cell anaemia (SCA) could optimize dosing and improve outcomes, but its feasibility has not been demonstrated in low‐resource settings where the majority of affected children live.
Alexandra Power‐Hays   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy